247 related articles for article (PubMed ID: 7650890)
1. Efficacy of a temperature-sensitive Sendai virus vaccine in hamsters.
Tagaya M; Mori I; Miyadai T; Kimura Y; Ito H; Nakakuki K
Lab Anim Sci; 1995 Jun; 45(3):233-8. PubMed ID: 7650890
[TBL] [Abstract][Full Text] [Related]
2. Protective effect of inactivated virus vaccine on Sendai virus infection in rats.
Tsukui M; Ito H; Tada M; Nakata M; Miyajima H; Fujiwara K
Lab Anim Sci; 1982 Apr; 32(2):143-6. PubMed ID: 6281572
[TBL] [Abstract][Full Text] [Related]
3. Aerosol vaccination with a sendai virus temperature-sensitive mutant (HVJ-pB) derived from persistently infected cells.
Iwata H; Tagaya M; Matsumoto K; Miyadai T; Yokochi T; Kimura Y
J Infect Dis; 1990 Aug; 162(2):402-7. PubMed ID: 1695654
[TBL] [Abstract][Full Text] [Related]
4. Combined oral/nasal immunization protects mice from Sendai virus infection.
Nedrud JG; Liang XP; Hague N; Lamm ME
J Immunol; 1987 Nov; 139(10):3484-92. PubMed ID: 2824609
[TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of intranasal vaccination with subunit Sendai virus vaccine in mice.
Ito H; Matumoto M
Jpn J Exp Med; 1986 Jun; 56(3):125-9. PubMed ID: 3020282
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a protease activation mutant of Sendai virus as a potent live vaccine.
Maru M; Haraguchi M; Sato K; Hotta H; Homma M
Vet Microbiol; 1992 Jan; 30(1):1-12. PubMed ID: 1311131
[TBL] [Abstract][Full Text] [Related]
7. Protection of mice against virulent virus infection by a temperature-sensitive mutant derived from an HVJ (Sendai virus) carrier culture.
Kimura Y; Aoki H; Shimokata K; Ito Y; Takano M; Hirabayashi N; Norrby E
Arch Virol; 1979; 61(4):297-304. PubMed ID: 229796
[TBL] [Abstract][Full Text] [Related]
8. Eradication of Sendai pneumonitis from a conventional mouse colony.
Eaton GJ; Lerro A; Custer RP; Crane AR
Lab Anim Sci; 1982 Aug; 32(4):384-6. PubMed ID: 6292576
[No Abstract] [Full Text] [Related]
9. Human parainfluenza virus type 1 immunization of infant mice protects from subsequent Sendai virus infection.
Sangster M; Smith FS; Coleclough C; Hurwitz JL
Virology; 1995 Sep; 212(1):13-9. PubMed ID: 7676623
[TBL] [Abstract][Full Text] [Related]
10. Protection of weanling hamsters from experimental infection with wild-type parainfluenza virus type 3 (para 3) by cold-adapted mutants of para 3.
Crookshanks-Newman FK; Belshe RB
J Med Virol; 1986 Feb; 18(2):131-7. PubMed ID: 3005486
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of an intranasal modified live bovine respiratory syncytial virus and temperature-sensitive parainfluenza type 3 virus vaccine in 3-week-old calves experimentally challenged with PI3V.
Vangeel I; Ioannou F; Riegler L; Salt JS; Harmeyer SS
Vet J; 2009 Jan; 179(1):101-8. PubMed ID: 17931918
[TBL] [Abstract][Full Text] [Related]
12. An inactivated parainfluenza virus type 3 vaccine: the influence of vaccination regime on the response of calves and their subsequent resistance to challenge.
Probert M; Stott EJ; Thomas LH; Collins AP; Jebbett J
Res Vet Sci; 1978 Mar; 24(2):222-7. PubMed ID: 206935
[TBL] [Abstract][Full Text] [Related]
13. Vaccination against parainfluenza 1 virus (typus muris) infection in order to eradicate this virus in colonies of laboratory animals.
Fukumi H; Takeuchi Y
Dev Biol Stand; 1975; 28():477-81. PubMed ID: 165125
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.
Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR
Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364
[TBL] [Abstract][Full Text] [Related]
15. [Susceptibility of mice to Sendai virus infection].
Iwai H
Jikken Dobutsu; 1984 Jul; 33(3):275-82. PubMed ID: 6094220
[No Abstract] [Full Text] [Related]
16. A chimeric alphavirus RNA replicon gene-based vaccine for human parainfluenza virus type 3 induces protective immunity against intranasal virus challenge.
Greer CE; Zhou F; Legg HS; Tang Z; Perri S; Sloan BA; Megede JZ; Uematsu Y; Vajdy M; Polo JM
Vaccine; 2007 Jan; 25(3):481-9. PubMed ID: 17052811
[TBL] [Abstract][Full Text] [Related]
17. Introducing point and deletion mutations into the P/C gene of human parainfluenza virus type 1 (HPIV1) by reverse genetics generates attenuated and efficacious vaccine candidates.
Bartlett EJ; Amaro-Carambot E; Surman SR; Collins PL; Murphy BR; Skiadopoulos MH
Vaccine; 2006 Mar; 24(14):2674-84. PubMed ID: 16364511
[TBL] [Abstract][Full Text] [Related]
18. A live human parainfluenza type 3 virus vaccine is attenuated and immunogenic in young infants.
Karron RA; Belshe RB; Wright PF; Thumar B; Burns B; Newman F; Cannon JC; Thompson J; Tsai T; Paschalis M; Wu SL; Mitcho Y; Hackell J; Murphy BR; Tatem JM
Pediatr Infect Dis J; 2003 May; 22(5):394-405. PubMed ID: 12792378
[TBL] [Abstract][Full Text] [Related]
19. The immune response and maternal antibody interference to a heterologous H1N1 swine influenza virus infection following vaccination.
Kitikoon P; Nilubol D; Erickson BJ; Janke BH; Hoover TC; Sornsen SA; Thacker EL
Vet Immunol Immunopathol; 2006 Aug; 112(3-4):117-28. PubMed ID: 16621020
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus infection in the laboratory rat: immunization trials using attenuated virus replicated in L-2 cells.
Percy DH; Scott RA
Can J Vet Res; 1991 Jan; 55(1):60-6. PubMed ID: 1653100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
